| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 301 | 305 | 333 | 352 |
| Cost of Material Consumed | 97 | 98 | 106 | 106 |
| Change in Inventory | 0 | 0 | -2 | 1 |
| Gross Margins | 67.77 | 67.87 | 68.77 | 69.6 |
| Employee Benefit Expenses | 53 | 54 | 54 | 65 |
| Other Expenses | 83 | 92 | 108 | 128 |
| EBITDA | 68 | 61 | 67 | 52 |
| OPM | 22.59 | 20 | 20.12 | 14.77 |
| Other Income | 4 | 5 | 5 | 8.5 |
| Finance Cost | 27 | 27 | 22 | 20 |
| D&A | 24 | 24 | 25 | 25 |
| EBIT | 44 | 37 | 42 | 27 |
| EBIT Margins | 14.62 | 12.13 | 12.61 | 7.67 |
| PBT | 21 | 16 | 24 | 16 |
| PBT Margins | 6.98 | 5.25 | 7.21 | 4.55 |
| Tax | 0 | 0 | 0 | 1 |
| PAT | 21 | 16 | 24 | 15 |
| NPM | 6.98 | 5.25 | 7.21 | 4.26 |
| EPS | 1.28 | 0.97 | 1.4 | 0.8 |
| Financial Ratios | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 22.59 | 20 | 20.12 | 14.77 |
| Net Profit Margin | 6.98 | 5.25 | 7.21 | 4.26 |
| Earning Per Share (Diluted) | 1.28 | 0.97 | 1.4 | 0.8 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 331 | 332 | 330 | 325 |
| CWIP | 10 | 12 | 82 | 285 |
| Investments | 1 | 1 | 1 | 1 |
| Trade Receivables | 9 | 17 | 30 | 23 |
| Inventory | 6.5 | 9 | 13 | 16.5 |
| Other Assets | 47.5 | 50 | 96 | 160.5 |
| Total Assets | 405 | 421 | 545 | 811 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 164.37 | 164.37 | 171 | 188.65 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | -46 | -31 | 24 | 129 |
| Borrowings | 256 | 243 | 291 | 425 |
| Trade Payables | 6 | 12 | 30 | 34 |
| Other Liabilities | 24.63 | 32.63 | 29 | 34.35 |
| Total Liabilities | 405 | 421 | 545 | 811 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | 21 | 16 | 24 | 16 |
| OPBWC | 71 | 65 | 69 | 57 |
| Change in Receivables | -0.53 | -8 | -66 | 0.7 |
| Change in Inventories | 0.42 | -2 | -43 | -3.6 |
| Change in Payables | 0 | 0 | 0 | 0 |
| Other Changes | 12.11 | 4 | 127 | -0.1 |
| Working Capital Change | 12 | -6 | 18 | -3 |
| Cash Generated From Operations | 83 | 59 | 87 | 54 |
| Tax | 0 | 0 | 0 | -1 |
| Cash Flow From Operations | 83 | 59 | 87 | 53 |
| Purchase of PPE | -34 | -15 | -10 | -19 |
| Sale of PPE | 0 | 0 | 0 | 0 |
| Cash Flow From Investment | -43 | -26 | -90 | -218 |
| Borrowing | 5.5 | -9 | 17 | 144 |
| Dividend | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 36.5 | 108 |
| Others From Financing | -40.5 | -27 | -28.5 | -60 |
| Cash Flow from Financing | -35 | -36 | 25 | 192 |
| Net Cash Generated | 5 | -3 | 22 | 27 |
| Cash at the Start | 3 | 8 | 5 | 27 |
| Cash at the End | 8 | 5 | 27 | 54 |
Royalcare Super Speciality Hospitals is an emerging healthcare institution known for offering advanced medical services with a strong focus on patient-centric care. Based in Coimbatore, the hospital has established itself as a trusted name in multi-speciality healthcare, combining modern infrastructure, highly qualified doctors, and cutting-edge technology. Its facilities include advanced ICUs, modular operation theatres, diagnostic labs, emergency care units, and specialized centres for cardiology, oncology, neurology, orthopaedics, gastroenterology, and nephrology. With a mission to deliver world-class healthcare at accessible cost, Royalcare has steadily grown its reputation in Tamil Nadu and neighbouring regions.
Over the years, Royalcare Super Speciality Hospitals has expanded its service portfolio to address the rising demand for comprehensive and specialized medical treatments. The hospital places strong emphasis on clinical excellence, adopting global protocols, and ensuring precision-based diagnosis and treatment. Royalcare’s team of experienced specialists and multi-disciplinary medical staff contributes significantly to its strong clinical outcomes and patient trust. The hospital also invests heavily in technological advancements—such as robotic-assisted procedures, high-end imaging systems, and minimally invasive surgical solutions—enhancing the quality and efficiency of care. Its focus on hospitality, hygiene, and patient comfort further strengthens its positioning as a premium healthcare provider.
The growth of Royalcare Super Speciality Hospitals also aligns with the increasing demand for quality healthcare in tier-2 and tier-3 Indian cities. As patients seek advanced treatments closer to home, institutions like Royalcare are well placed to capture significant market share. The hospital’s planned expansions, service diversification, and emphasis on holistic wellness support long-term sustainability. Its strong brand reputation, modern medical capabilities, and commitment to ethical healthcare make it an attractive name in the private healthcare segment. With the Indian healthcare industry poised for rapid growth, Royalcare Super Speciality Hospitals is well positioned to continue expanding its footprint and delivering superior medical outcomes to a broadening patient base.
Q:1 How do I confirm my booking for Royalcare Super Speciality Hospitals shares?Answer: You can confirm your booking by contacting us and agreeing on a trading price for the unlisted shares of Royalcare Super Speciality Hospitals.
Q:2 What documents do I need to provide for the purchase?Answer: You need to provide your client master report, PAN Card, and a cancelled cheque.If you don’t have the client master report, please ask your broker for assistance.
Q:3 Why do I need to provide KYC documents?
Answer: KYC documents are required as per SEBI regulations to ensure compliance and to verify the identity of the investor.
Q:4 What payment methods are accepted for purchasing shares?
Answer: Payments must be made via RTGS, NEFT, IMPS, or cheque transfer.Note that cash deposits are not accepted.
Q:5 From which bank account should I make the payment?
Answer: The payment must be made from the same bank account that will be used to credit the shares.
Q:6 Will you provide the bank details for the transaction?
Answer: Yes, we will provide you with the necessary bank details for transferring the funds.
Q:7 What happens if I don’t have a cancelled cheque?
Answer: If you don’t have a cancelled cheque, you may need to discuss alternative options with us to fulfill the KYC requirements.
Q:8 Can I transfer funds from a different account than the one linked to my shares?Answer: No, you must transfer funds from the same account as stated in your client master report for the shares to be credited correctly.